betrixaban News
Most Popular betrixaban Story
Portola, Merck report postitive betrixaban results
Fierce 15 company Portola Pharmaceuticals and Merck today announced the results of a Phase II dose-finding study of betrixaban at the American College of Cardiology meeting. In the study, a Read more...
Latest Headlines
- November 21, 2011
- October 27, 2011
- March 15, 2010
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
